These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30643055)

  • 21. Epigenetic suppression of Fli1, a potential predisposing factor in the pathogenesis of systemic sclerosis.
    Asano Y
    Int J Biochem Cell Biol; 2015 Oct; 67():86-91. PubMed ID: 26055516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global DNA hypomethylation and hypoxia-induced expression of the ten eleven translocation (TET) family, TET1, in scleroderma fibroblasts.
    Hattori M; Yokoyama Y; Hattori T; Motegi S; Amano H; Hatada I; Ishikawa O
    Exp Dermatol; 2015 Nov; 24(11):841-6. PubMed ID: 26013976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global hypomethylation pattern in systemic sclerosis: An application for absolute quantification of epigenetic DNA modification products by 2D-UPLC-MS/MS.
    Dal-Bekar NE; Siomek-Gorecka A; Gackowski D; Köken-Avşar A; Yarkan-Tuğsal H; Birlik M; İşlekel H
    Clin Immunol; 2022 Jun; 239():108997. PubMed ID: 35398518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic factors and systemic sclerosis.
    Murdaca G; Contatore M; Gulli R; Mandich P; Puppo F
    Autoimmun Rev; 2016 May; 15(5):427-32. PubMed ID: 26826434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A Uuifying hypothesis for the pathogenesis of systemic sclerosis based on the deficiency of transcription factor Fli1 - the development of a new animal model of systemic sclerosis -].
    Asano Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):475-87. PubMed ID: 25748132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy.
    Henry TW; Mendoza FA; Jimenez SA
    Autoimmun Rev; 2019 Nov; 18(11):102396. PubMed ID: 31520794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic sclerosis: genetics and epigenetics.
    Luo Y; Wang Y; Wang Q; Xiao R; Lu Q
    J Autoimmun; 2013 Mar; 41():161-7. PubMed ID: 23415078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential DNA Methylation Landscape in Skin Fibroblasts from African Americans with Systemic Sclerosis.
    Baker Frost D; da Silveira W; Hazard ES; Atanelishvili I; Wilson RC; Flume J; Day KL; Oates JC; Bogatkevich GS; Feghali-Bostwick C; Hardiman G; Ramos PS
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33498390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Epigenetic Modifications in Systemic Sclerosis: A Druggable Target.
    Henderson J; Distler J; O'Reilly S
    Trends Mol Med; 2019 May; 25(5):395-411. PubMed ID: 30858032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis.
    Svegliati S; Marrone G; Pezone A; Spadoni T; Grieco A; Moroncini G; Grieco D; Vinciguerra M; Agnese S; Jüngel A; Distler O; Musti AM; Gabrielli A; Avvedimento EV
    Sci Signal; 2014 Sep; 7(341):ra84. PubMed ID: 25185156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenic roles of B lymphocytes in systemic sclerosis.
    Yoshizaki A
    Immunol Lett; 2018 Mar; 195():76-82. PubMed ID: 29307688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic modulation as a therapy in systemic sclerosis.
    O'Reilly S
    Rheumatology (Oxford); 2019 Feb; 58(2):191-196. PubMed ID: 29579252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
    Jimenez SA; Piera-Velazquez S
    Matrix Biol; 2016 Apr; 51():26-36. PubMed ID: 26807760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis.
    Taniguchi T; Asano Y; Nakamura K; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S
    J Rheumatol; 2017 Aug; 44(8):1198-1205. PubMed ID: 28507181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly(ADP-ribose) polymerase-1 regulates fibroblast activation in systemic sclerosis.
    Zhang Y; Pötter S; Chen CW; Liang R; Gelse K; Ludolph I; Horch RE; Distler O; Schett G; Distler JHW; Dees C
    Ann Rheum Dis; 2018 May; 77(5):744-751. PubMed ID: 29431122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin β3.
    Honda N; Jinnin M; Kira-Etoh T; Makino K; Kajihara I; Makino T; Fukushima S; Inoue Y; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    Am J Pathol; 2013 Jan; 182(1):206-16. PubMed ID: 23159943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of genetics and epigenetics in the pathogenesis of systemic sclerosis.
    Broen JC; Radstake TR; Rossato M
    Nat Rev Rheumatol; 2014 Nov; 10(11):671-81. PubMed ID: 25136786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.
    Noda S; Asano Y; Nishimura S; Taniguchi T; Fujiu K; Manabe I; Nakamura K; Yamashita T; Saigusa R; Akamata K; Takahashi T; Ichimura Y; Toyama T; Tsuruta D; Trojanowska M; Nagai R; Sato S
    Nat Commun; 2014 Dec; 5():5797. PubMed ID: 25504335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sirt1 ameliorates systemic sclerosis by targeting the mTOR pathway.
    Zhu X; Chu H; Jiang S; Liu Q; Liu L; Xue Y; Zheng S; Wan W; Qiu J; Wang J; Zou H
    J Dermatol Sci; 2017 Aug; 87(2):149-158. PubMed ID: 28532580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of OASL upregulates TET1 to induce aberrant activation of CD4
    Zeng Z; Wang Y; Xiao Y; Zheng J; Liu R; He X; Yu J; Tang B; Qiu X; Tang R; Shi Y; Xiao R
    Arthritis Res Ther; 2022 Feb; 24(1):50. PubMed ID: 35183246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.